Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Formulated Solutions LLC has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, so at least one examiner handles more than one pending action and the examination is concentrated within two units.
TRUONG, QUANGLONG N is the busiest examiner, with 2 pending matters. Counsel can coordinate issues across that examiner’s matters while maintaining a separate review for the remaining action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRUONG, QUANGLONG N | 2 | 78.6% | +23.3% |
| ZADEH, BOB | 1 | 76.9% | +38.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17887092 | CRYOGENIC, KINETICALLY ACTIVE FORMULATIONS AND SYSTEMS FOR THEIR DISPENSING | ZADEH, BOB | 74d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17887092 | CRYOGENIC, KINETICALLY ACTIVE FORMULATIONS AND SYSTEMS FOR THEIR DISPENSING | ZADEH, BOB | 74d overdue |
| 18950919 | WHIPPED FORMULATIONS | TRUONG, QUANGLONG N | — |
| 18929954 | WHIPPED FORMULATIONS | TRUONG, QUANGLONG N | — |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 3754 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18950919 | WHIPPED FORMULATIONS | TRUONG, QUANGLONG N | 1615 | §103DP | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18929954 | WHIPPED FORMULATIONS | TRUONG, QUANGLONG N | 1615 | §103DP | Non-Final OA | — | Pending | Oct 29, 2024 |
| 17887092 | CRYOGENIC, KINETICALLY ACTIVE FORMULATIONS AND SYSTEMS FOR THEIR DISPENSING | ZADEH, BOB | 3754 | §102§103§112 | Non-Final OA | 74d overdue | Pending | Aug 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFormulated Solutions LLC has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Quanglong N Truong has the most, with 2 of Formulated Solutions LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
